Skip to main content
. 2023 Oct 26;34:100737. doi: 10.1016/j.lanepe.2023.100737

Fig. 2.

Fig. 2

Summary Figure. Legend. CEFT, Ceftriaxone; AZI, Azithromycin; SPE, Spectinomycin; GEN, Gentamicin; CIP, Ciprofloxacin; ERT, Ertapenem; CEFI, Cefixime; JOS, Josamycin; MOX, Moxifloxacin; PRIS, Pristinamycin; MINO, Minocycline; LEF, Lefamulin; ZOL, Zoliflodacin; GEP, Gepotidacin; SIT, Sitafloxacin, SOL, Solithromycin; OMA, Omadacycline; ERA, Eravacycline; TIN, Tinidazole; LIN, Linezolid; CT, Clinical Trial; AMR, Antimicrobial resistance.